Table 1

Summary of anthropometric data and baseline characteristics

ParameterStage IStage II
Total (n=27)SET (n=15)Placebo (n=12)Total (n=42)SET (n=21)Placebo (n=21)
Age (years)±SD31.6±9.329.2±8.834.6±9.329.7±8.730.7±7.628.7±9.8
Height (m)±SD1.81±0.061.79±0.061.83±0.071.83±0.051.84±0.061.82±0.04
Weight (kg)±SD80.0±10,076.5±10.284.3±8.081.2±7.481.0±8.681.3±61
BMI (kg/m2)±SD24.4±2.123.8±2.025.2±1.924.3±1.824.0±1.824.6±1.8
Sport activity (min/week)±SD369±206415±197312±211482±433483±502481±363
CK (U/L)±SD214±157227±148199±122244±165225±160264±172
PTM/BW (Nm/kg)±SD2.76±0.442.76±0.512.75±0.342.82±0.512.75±0,532.89±0.48

  • Anthropometric data, sporting activity and creatine kinase were assessed at screening; peak torque maximum/body weight was measured the day before start of supplementation.

  • BMI, body mass index; CK, creatine kinase; Nm, newton metre; PTM/BW, peak torque maximum/body weight; SET, systemic enzyme therapy.